Clinical utility of Epstein‐Barr virus DNA and other liquid biopsy markers in nasopharyngeal carcinoma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical utility of Epstein‐Barr virus DNA and other liquid biopsy markers in nasopharyngeal carcinoma
Authors
Keywords
-
Journal
Cancer Communications
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-09-29
DOI
10.1002/cac2.12100
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Detection of Circulating Tumor Cells in the Diagnostic Leukapheresis Product of Non-Small-Cell Lung Cancer Patients Comparing CellSearch® and ISET
- (2020) Menno Tamminga et al. Cancers
- Integrating postradiotherapy plasma Epstein–Barr virus DNA and TNM stage for risk stratification of nasopharyngeal carcinoma to adjuvant therapy
- (2020) E.P. Hui et al. ANNALS OF ONCOLOGY
- Plasma Epstein-Barr virus DNA as an archetypal circulating tumour DNA marker
- (2019) Wai Kei Jacky Lam et al. JOURNAL OF PATHOLOGY
- Relationship of Circulating Tumor Cells and Epstein‐Barr Virus DNA to Progression‐Free Survival and Overall Survival in Metastatic Nasopharyngeal Carcinoma Patients
- (2019) Rui You et al. INTERNATIONAL JOURNAL OF CANCER
- Methylation analysis of plasma DNA informs etiologies of Epstein-Barr virus-associated diseases
- (2019) W. K. Jacky Lam et al. Nature Communications
- Epstein-Barr virus-encoded microRNAs as regulators in host immune responses
- (2018) Man Wang et al. International Journal of Biological Sciences
- Evaluation of circulating EBV microRNA BART2-5p in facilitating early detection and screening of nasopharyngeal carcinoma
- (2018) Chen Jiang et al. INTERNATIONAL JOURNAL OF CANCER
- Analysis of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Cancer After Chemoradiation to Identify High-Risk Patients for Adjuvant Chemotherapy: A Randomized Controlled Trial
- (2018) Anthony T.C. Chan et al. JOURNAL OF CLINICAL ONCOLOGY
- Sequencing-based counting and size profiling of plasma Epstein–Barr virus DNA enhance population screening of nasopharyngeal carcinoma
- (2018) W. K. Jacky Lam et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Size-Based Enrichment Technologies for Non-cancerous Tumor-Derived Cells in Blood
- (2018) Jamie Mong et al. TRENDS IN BIOTECHNOLOGY
- Assessment of the Long-term Diagnostic Performance of a New Serological Screening Scheme in Large-scale Nasopharyngeal Carcinoma Screening
- (2018) Xia Yu et al. Journal of Cancer
- Establishment and validation of a two-step screening scheme for improved performance of serological screening of nasopharyngeal carcinoma
- (2018) Tingdong Li et al. Cancer Medicine
- The emerging role of Epstein-Barr virus encoded microRNAs in nasopharyngeal carcinoma
- (2018) Chunmei Fan et al. Journal of Cancer
- Current Role of Chemotherapy in Nonmetastatic Nasopharyngeal Cancer
- (2018) Tapesh Bhattacharyya et al. Journal of Oncology
- Prevalence and significance of plasma Epstein-Barr Virus DNA level in nasopharyngeal carcinoma
- (2017) Anussara Prayongrat et al. JOURNAL OF RADIATION RESEARCH
- Analysis of Plasma Epstein–Barr Virus DNA to Screen for Nasopharyngeal Cancer
- (2017) K.C. Allen Chan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Epstein–Barr virus infection and nasopharyngeal carcinoma
- (2017) Sai Wah Tsao et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Circulating tumor cells in the blood of poorly differentiated nasal squamous cell carcinoma patients: correlation with treatment response
- (2016) Feng Li et al. ACTA OTO-LARYNGOLOGICA
- MicroRNAs serving as potential biomarkers and therapeutic targets in nasopharyngeal carcinoma: A critical review
- (2016) Katherine Ting-Wei Lee et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Distribution and clinical significance of circulating tumor cells in nasopharyngeal carcinoma
- (2016) Yongfeng Si et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Epstein–Barr virus DNA level as a novel prognostic factor in nasopharyngeal carcinoma
- (2016) Jing Zhang et al. MEDICINE
- Prognostic Impact of Plasma Epstein-Barr Virus DNA in Patients with Nasopharyngeal Carcinoma Treated using Intensity-Modulated Radiation Therapy
- (2016) Hao Peng et al. Scientific Reports
- Potential Interest in Circulating miR-BART17-5p As a Post-Treatment Biomarker for Prediction of Recurrence in Epstein-Barr Virus-Related Nasopharyngeal Carcinoma
- (2016) Nobuyuki Hirai et al. PLoS One
- Comparison of Circulating Tumour Cells and Circulating Cell-Free Epstein-Barr Virus DNA in Patients with Nasopharyngeal Carcinoma Undergoing Radiotherapy
- (2016) Jess Honganh Vo et al. Scientific Reports
- Cell-free Epstein-Barr virus-DNA in patients with nasopharyngeal carcinoma: Plasma versus urine
- (2015) Manju Sengar et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Genome-Wide Identification of a Methylation Gene Panel as a Prognostic Biomarker in Nasopharyngeal Carcinoma
- (2015) W. Jiang et al. MOLECULAR CANCER THERAPEUTICS
- Characterization of the nasopharyngeal carcinoma methylome identifies aberrant disruption of key signaling pathways and methylated tumor suppressor genes
- (2015) Lili Li et al. Epigenomics
- Epstein-Barr virus mir-bart1-5p detection via nasopharyngeal brush sampling is effective for diagnosing nasopharyngeal carcinoma
- (2015) Xiao-Hui Zheng et al. Oncotarget
- Nasopharyngeal Epstein-Barr Virus Load: An Efficient Supplementary Method for Population-Based Nasopharyngeal Carcinoma Screening
- (2015) Yufeng Chen et al. PLoS One
- Diagnostic Significance of Combined Detection of Epstein-Barr Virus Antibodies, VCA/IgA, EA/IgA, Rta/IgG and EBNA1/IgA for Nasopharyngeal Carcinoma
- (2014) Yong-Lin Cai et al. Asian Pacific Journal of Cancer Prevention
- Epigenetic markers for noninvasive early detection of nasopharyngeal carcinoma by methylation-sensitive high resolution melting
- (2014) Xuesong Yang et al. INTERNATIONAL JOURNAL OF CANCER
- Circulating Epstein-Barr virus microRNAs miR-BART7 and miR-BART13 as biomarkers for nasopharyngeal carcinoma diagnosis and treatment
- (2014) Gaohong Zhang et al. INTERNATIONAL JOURNAL OF CANCER
- Commutability of the Epstein-Barr Virus WHO International Standard across Two Quantitative PCR Methods
- (2014) J. Abeynayake et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Early detection of nasopharyngeal carcinoma by plasma Epstein-Barr virus DNA analysis in a surveillance program
- (2013) K. C. Allen Chan et al. CANCER
- Promoter hypermethylation of tumor suppressor genes in serum as potential biomarker for the diagnosis of nasopharyngeal carcinoma
- (2013) Fangyun Tian et al. Cancer Epidemiology
- Real-time Liquid Biopsy in Cancer Patients: Fact or Fiction?
- (2013) K. Pantel et al. CANCER RESEARCH
- Clinical scenario of EBV DNA follow-up in patients of treated localized nasopharyngeal carcinoma
- (2013) Cheng-Lung Hsu et al. ORAL ONCOLOGY
- Two Epstein-Barr Virus-Related Serologic Antibody Tests in Nasopharyngeal Carcinoma Screening: Results From the Initial Phase of a Cluster Randomized Controlled Trial in Southern China
- (2012) Z. Liu et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Role of plasma EBV DNA levels in predicting recurrence of nasopharyngeal carcinoma in a western population
- (2012) Daris Ferrari et al. BMC CANCER
- Epstein–Barr virus early antigen diffuse (EBV-EA/D)-directed immunoglobulin A antibodies in systemic lupus erythematosus patients
- (2012) AH Draborg et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- Plasma Epstein-Barr virus DNA screening followed by 18F-fluoro-2-deoxy-D-glucose positron emission tomography in detecting posttreatment failures of nasopharyngeal carcinoma
- (2011) Wen-Yi Wang et al. CANCER
- CDH4 as a novel putative tumor suppressor gene epigenetically silenced by promoter hypermethylation in nasopharyngeal carcinoma
- (2011) Chunping Du et al. CANCER LETTERS
- Detection of Epstein-Barr Virus DNA in Serum or Plasma for Nasopharyngeal Cancer: A Meta-Analysis
- (2011) Yu Liu et al. Genetic Testing and Molecular Biomarkers
- The prevalence and prevention of nasopharyngeal carcinoma in China
- (2011) Su-Mei Cao et al. Chinese Journal of Cancer
- Viral hit and run-oncogenesis: Genetic and epigenetic scenarios
- (2010) Hans Helmut Niller et al. CANCER LETTERS
- Plasma EBV DNA Clearance Rate as a Novel Prognostic Marker for Metastatic/Recurrent Nasopharyngeal Carcinoma
- (2010) W.-Y. Wang et al. CLINICAL CANCER RESEARCH
- Infectious Mononucleosis
- (2010) Katherine Luzuriaga et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interlaboratory Comparison of Epstein-Barr Virus Viral Load Assays
- (2009) J. K. Preiksaitis et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Activation of DNA Methyltransferase 1 by EBV Latent Membrane Protein 2A Leads to Promoter Hypermethylation of PTEN Gene in Gastric Carcinoma
- (2009) R. Hino et al. CANCER RESEARCH
- Outcomes of nasopharyngeal carcinoma screening for high risk family members in Hong Kong
- (2009) Wai Tong Ng et al. Familial Cancer
- Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: A possible alternative for primary screening of nasopharyngeal carcinoma
- (2008) Kai-Ping Chang et al. ORAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now